Compounds from olive (Olea europaea L.) and pomegranate (Punica granatum L.) have many beneficial effects on human health. This review paper considers the inhibitory potential, under in vitro conditions, of bioactive components of olive and pomegranate on different enzyme systems. Research shows that olive polyphenols (oleuropein, hydroxytyrosol, luteolin, and oleocanthal), as well as pomegranate polyphenols (punicalagin, urolithin A, ellagic acid), inhibit cyclooxygenase and lipoxygenase enzymes, which are associated with inflammatory processes. They also show an inhibitory effect on acetylcholinesterase, butyrylcholinesterase, and β-secretase, which opens up the possibility of a strong neuroprotective effect. Olive and pomegranate polyphenols also have an inhibitory effect on enzymes involved in carbohydrate metabolism, such as amylase and glucosidase, and can help fight diabetes and regulate human metabolism. In addition, polyphenols and extracts of both plants showed an inhibitory effect on cytochrome P450 enzymes, which metabolize most drugs. These data open up the possibility of interactions with certain groups of drugs. The current evidence supports the view that olive and pomegranate polyphenols act as biologically versatile compounds with considerable pharmaceutical and nutraceutical potential. Future investigations integrating enzymology, metabolomics, molecular docking, and clinical validation will be essential for translating these promising in vitro findings into evidence-based therapeutic applications.

BACKGROUND Enteric infectious diseases claim more than 1 million lives annually and are among the top ten causes of death in children younger than 5 years. Remarkable global investment has been dedicated to enteric infectious disease prevention and control; however, the shifting global health landscape is testing the continuance of progress. To evaluate the current status and guide future interventions, we present the latest epidemiological estimates of enteric infectious diseases from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 and assess progress towards the Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) mortality target of fewer than 20 deaths per 100 000 children younger than 5 years by 2025. METHODS We quantified the incidence, mortality, and disability-adjusted life-years (DALYs) of enteric infectious diseases by age, sex, and year across 204 countries and territories from 1990 to 2023. In GBD 2023, the following were considered under the category of enteric infectious diseases: diarrhoeal diseases, enteric fever (typhoid and paratyphoid), invasive non-typhoidal Salmonella spp (iNTS) infections, and other intestinal infectious diseases. We also examined 15 aetiologies contributing to diarrhoeal diseases. Incidence and prevalence were estimated with DisMod-MR (version 2.1), a Bayesian meta-regression tool, drawing on data from systematic reviews, population-based surveys, claims data, and hospital sources. Cause-specific mortality was modelled with Cause of Death Ensemble Modelling based on data from sources including vital registration, mortality surveillance, verbal autopsy, and minimally invasive tissue sampling. Years of life lost and years lived with disability were computed and combined to derive DALYs. For aetiology-specific estimation, population-attributable fractions (PAFs) for 15 pathogens were derived with a counterfactual framework. Point estimates and 95% uncertainty intervals (UIs) were generated from 250 draws from the posterior distribution. FINDINGS In 2023, enteric infectious diseases resulted in an estimated 1·27 million (95% UI 0·963-1·68) deaths globally, declining from 3·69 million (3·04-4·56) in 1990. The global age-standardised mortality rate (ASMR) decreased from 74·1 (62·0-92·9) per 100 000 population to 16·4 (12·6-21·3) per 100 000 population during the same period. Diarrhoeal diseases accounted for most deaths in 2023 (1·11 million [0·811-1·54]), followed by enteric fever and iNTS. South Asia and sub-Saharan Africa remained the most affected regions in 2023, with 599 000 (441 000-882 000) and 501 000 (373 000-648 000) deaths due to enteric infectious diseases, respectively, predominantly from diarrhoeal disease. Rotavirus was the leading cause of all-age diarrhoeal disease deaths (PAF 16·3% [12·0-21·5]), followed by norovirus (10·2% [2·4-17·0]) and Shigella spp (9·3% [5·4-15·2]). Among children younger than 5 years, PAFs of deaths due to diarrhoeal diseases were 40·2% (32·5-48·5) for rotavirus, 24·0% (15·1-36·7) for Shigella spp, and 23·4% (13·7-34·3) for adenovirus. Across 204 countries and territories, 141 met the GAPPD mortality target in 2023. The driving aetiologies among countries that did not meet the target in 2023 varied slightly by GBD super-region, but the highest or second-highest number of deaths in children younger than 5 years were consistently attributed to rotavirus. Astrovirus and sapovirus, newly included in GBD 2023, were responsible for 24 600 (6290-49 000) and 18 800 (4650-44 400) deaths, respectively, in 2023, mainly in children younger than 5 years. INTERPRETATION Our findings show that mortality and ASMRs of enteric infectious diseases declined substantially between 1990 and 2023. This decline is consistent with the expansion of public health measures and broader socioeconomic development. However, the burden in 2023 remains considerably high, with the highest mortality concentrated in sub-Saharan Africa and south Asia. Considering that more than a quarter of all countries had yet to meet the GAPPD mortality target in 2023, sustained efforts are needed to address the persistent burden in affected countries and to adapt to the changing global health landscape. FUNDING Gates Foundation.

Background: Hofbauer cells (HBCs) are the only immunocompetent cells within the stroma of chorionic villi and play a key role in immune regulation and placental development throughout gestation. Their phenotype, abundance, and proliferative activity change in accordance with the needs of the fetoplacental unit. Methods: Thirty healthy human placentas across all three trimesters were analyzed. Samples were processed using standard histological protocols and immunohistochemically stained with CD45, CD68, CD86, and Ki-67 markers. Morphometric analysis was performed to determine the following parameters: percentage of HBCs, numerical areal density, and proliferative index. Results: HBCs were immunoreactive for CD45 and CD68, while CD86 immunoreactivity was not observed in any trimester. The proportion of HBCs was highest in the second trimester and lowest in the third. Numerical areal density was highest in the second trimester (22.21 ± 3.86) and lowest in the first (8.27 ± 4.18). The proliferative index was highest in the first trimester (82.45 ± 10.19%), decreased significantly in the second, and was completely absent in the third trimester. Conclusions: During physiological placental development, Hofbauer cells maintain a predominantly non-M1 macrophage phenotype, accompanied by a gradual reduction in proliferative activity.

Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and the leading cause of end‐stage renal disease. Oxidative stress and inflammation are central drivers of DN progression, yet no effective therapies exist to prevent or delay renal injury. This study investigated the renoprotective effects of glycine (GLY), N‐acetylcysteine (NAC), and their combination administered at early versus late stages of streptozotocin induced diabetes. Forty‐eight male Wistar rats (n = 48) were allocated into five groups: healthy controls (Group 1, n = 6), untreated diabetic rats (Group 2, n = 6), and three treatment groups (Groups 3–5, each n = 12). Diabetes was induced by a single intraperitoneal streptozotocin injection (55 mg/kg). Group 3 received NAC (100 mg/kg), Group 4 received GLY (250 mg/kg), and Group 5 received NAC + GLY. Each treatment group was subdivided into early (6 week, n = 6) and late (12 week, n = 6) intervention subgroups. Treatments were administered orally. Renal tissue was evaluated using classic histology, geometric morphometric analysis, and biochemical assays of superoxide dismutase (SOD) and myeloperoxidase (MPO). Statistical analyzes were performed using ANOVA with appropriate post hoc tests (p < 0.05). Untreated diabetic rats (Group 2) showed significantly decreased SOD activity, increased MPO levels, marked mesangial matrix expansion, glomerular hypercellularity, tubular epithelial degeneration, and interstitial inflammation with fibrosis. NAC (Group 3) and GLY (Group 4) each improved oxidative stress markers and partially restored glomerular and tubular morphology, with early treatment subgroups exhibiting more substantial benefit than late subgroups. The combined NAC + GLY therapy (Group 5) demonstrated the strongest renoprotective effect, preserving renal structure and biochemical parameters closest to healthy controls. To conclude, early combined administration of glycine and N‐acetylcysteine yields superior protection against diabetes‐induced renal injury compared with individual treatments. These findings support the therapeutic potential of antioxidant‐amino acid combinations in preventing or delaying diabetic nephropathy.

Background/objectives: Aneurysmal subarachnoid hemorrhage (aSAH) is a neurosurgical emergency associated with cerebral vasospasm, representing an important complication. This study assessed the association between cerebrospinal fluid (CSF) interleukin-6 (IL-6) levels and cerebral vasospasm after aSAH. Methods: This prospective single-center observational study with repeated measurements included 56 patients among 74 screened patients with aSAH; 18 patients were excluded according to predefined exclusion criteria, including infection, unavailable CSF samples or requirement for CSF diversion within the first seven days of onset. The samples were obtained via lumbar puncture on post-hemorrhage days 3 and 7. IL-6 was quantified using an electrochemiluminescent immunoassay. Radiological vasospasm (RV) was assessed by computed tomography angiography, while clinical vasospasm (CCV) was defined as new neurological deterioration unexplained by other causes. Results: Median IL-6 levels were 423.5 pg/mL on day 3 and 726.0 pg/mL on day 7. Day 7 IL-6 levels were associated with RV (p = 0.045) and CCV (p = 0.010), while day 3 IL-6 was associated with CCV only (p = 0.035). Day 7 IL-6 showed modest discriminatory performance for CCV: AUC = 0.722, cut-off 460 pg/mL, sensitivity 75.0%, and specificity 68.8%; for RV: AUC = 0.659, cut-off 451 pg/mL, sensitivity 81.8%, and specificity 56.5%. Conclusions: Elevated CSF IL-6 levels were associated with cerebral vasospasm after aSAH, with a more consistent association observed for CCV than for RV; however, these findings are hypothesis-generating and require validation before clinical applicability can be determined.

<p>The paper investigates students&rsquo; perceptions and attitudes toward extracurricular activities (ECAs) organized by the English Language and Literature Department at the University of Zenica (UNZE). While ECAs are widely acknowledged for their pedagogical value, their role in higher education contexts within Bosnia and Herzegovina remains heavily underexplored. In that sense, the study aim was to assess the perceived effect of ECAs, such as quizzes, conferences, and competitions, on students&rsquo; interpersonal, social, and speaking skills, motivation, as well as the practical application of their academic knowledge. Data for this quantitative study was collected through an online questionnaire containing Likert-scale and multiple-choice items, while the respondents included undergraduate students across all four study years. Responses reveal that a majority of students view ECAs positively and show high levels of motivation and willingness to participate in the said activities. In addition, most students recognize that participation in ECAs has enhanced their interpersonal and social skills while many also note improvements in their English speaking skills and increased motivation levels. Hence, study results contribute to discussions on learners&rsquo; motivation in higher education contexts and offer insights that may inform future institutional strategies concerning the general students&rsquo; engagement.</p>

Understanding students’ environmental values and behaviors is important for fostering sustainable practices through education. In this study, we investigated the measurement properties and structural relationships of the Students Value Environmental Preservation and Environmentally Responsible Behaviors scales from Trends in International Mathematics and Science Study (TIMSS) 2023 within the Norwegian context, using data from students in Grades 5 and 9. Confirmatory factor analysis (CFA) supported the hypothesized factor structure of both scales, indicating good reliability and validity. Multigroup CFA established partial measurement invariance across genders and showed that girls score significantly higher on environmental values and environmentally responsible behaviors than boys, with the gender gap more pronounced in Grade 9. In a series of structural equation models, we demonstrated that environmental values are a strong, consistent predictor of environmentally responsible behaviors across grades and gender. In contrast, science achievement showed weak or negative associations with responsible behaviors, particularly for Grade 9 boys, suggesting that academic success in science does not necessarily translate into pro-environmental behaviors. These findings highlight the importance of cultivating environmental values as a foundation for responsible behaviors and underscore the need for gender-responsive science education that connects values with real-world applications.

Spinal injuries represent a significant public health concern, causing severe impairments in bodily functions, including disrupted postural control and the loss of the ability to maintain an upright position. These functional difficulties substantially affect patients' quality of life and their engagement in daily activities. Traditional rehabilitation approaches often demonstrate limited effectiveness in achieving functional recovery. Consequently, recent years have witnessed rapid advancements in technological innovations within the rehabilitation process for spinal injuries. The integration of robotic systems, wearable technologies, and neurostimulation, presents new opportunities for improved therapeutic outcomes. These innovations not only enhance the precision of therapy but also enable personalized approaches tailored to the specific needs of each patient. Particular emphasis is placed on technological advancements that facilitate verticalization and improve postural control, as these functions are crucial for maintaining balance and participating in everyday activities. This paper aims to present and analyze some of the technological innovations in the rehabilitation of individuals with spinal injuries, with a particular focus on verticalization and postural control. Future research should concentrate on optimizing technological solutions, developing personalized therapeutic approaches, and ensuring accessibility to maximize functional benefits for individuals with spinal injuries. Keywords: technological innovations, verticalization, postural control, spinal cord injury